TGTX:NASDAQ
TG Therapeutics Inc common stock
$55.98
arrow_downward
-1.28%(-0.72) 1D
$56.00
arrow_upward
+0.03% (+0.015)bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TGTX...
Open
$56.30
High
$56.70
Low
$55.56
Mkt. cap
8.57B
Avg. vol.
2.22M
Volume
992.97K
P/E ratio
20.39
52-wk high
$59.30
52-wk low
$26.76
EPS
$2.75
Beta
1.67
Shares outstanding
153.07M
No. of employees
399
Open
$56.30
High
$56.70
Low
$55.56
Mkt. cap
8.57B
Avg. vol.
2.22M
Volume
992.97K
P/E ratio
20.39
52-wk high
$59.30
52-wk low
$26.76
EPS
$2.75
Beta
1.67
Shares outstanding
153.07M
No. of employees
399
News stories
From web sources and news partners
Simply Wall Street
·
13 hours ago
TG Therapeutics (TGTX) Stock Looks Fairly Valued After A 4x Run
Investor's Business Daily
·
2 days ago
IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point
Yahoo Finance
·
2 days ago
TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue?
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, North Carolina, United States
SectorBiotechnology
Websitetgtherapeutics.com